Featured Research

from universities, journals, and other organizations

Heart Risks From Vioxx Happen Much Earlier Than Believed

Date:
May 4, 2006
Source:
Queen's University
Summary:
A new study led by Queen's University researcher Linda Lévesque shows that heart attacks related to the use of Vioxx -- a drug once popular for the treatment of pain and inflammation -- can occur within the first two weeks of use.

A new study led by Queen's University researcher Linda Lévesque shows that heart attacks related to the use of Vioxx -- a drug once popular for the treatment of pain and inflammation -- can occur within the first two weeks of use.

Related Articles


A quarter of patients who suffered a heart attack while taking Vioxx did so within the first two weeks of their first Vioxx prescription, says Prof. Lévesque , of Queen's Department of Community Health and Epidemiology. "This demonstrates that cardiovascular risks from taking Vioxx may occur much earlier than previously believed."

Conducted with McGill University researchers James Brophy and Bin Zhang, the findings will be published on-line May 2 in the Canadian Medical Association Journal.

"Our previous study on COX-2 inhibitors, which included Vioxx and Celebrex, evaluated whether there was an increased risk of heart attack while taking these medications; the answer was yes for Vioxx," explains Prof. Lévesque. In the current study, funded by the Canadian Institutes for Health Research (CIHR), the pattern of cardiovascular risk in Québec seniors was assessed over a three-year period.

The additional cardiovascular risk actually decreased with longer duration of use, suggesting that the period of highest susceptibility for most people taking Vioxx may occur earlier than previously believed. The study also documents that cardiovascular risk returns to normal within one month of stopping the drug.

Vioxx was voluntarily withdrawn from the market on September 30, 2004 after a study showed that it doubled patients' risk of heart attacks and strokes after 18 months of use. This study is the first to specifically address the question of the timing of cardiovascular risk associated with COX-2 inhibitors.


Story Source:

The above story is based on materials provided by Queen's University. Note: Materials may be edited for content and length.


Cite This Page:

Queen's University. "Heart Risks From Vioxx Happen Much Earlier Than Believed." ScienceDaily. ScienceDaily, 4 May 2006. <www.sciencedaily.com/releases/2006/05/060504081246.htm>.
Queen's University. (2006, May 4). Heart Risks From Vioxx Happen Much Earlier Than Believed. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2006/05/060504081246.htm
Queen's University. "Heart Risks From Vioxx Happen Much Earlier Than Believed." ScienceDaily. www.sciencedaily.com/releases/2006/05/060504081246.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) — An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins